BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31805199)

  • 1. Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care.
    Olin RL
    Blood; 2019 Dec; 134(23):2013-2021. PubMed ID: 31805199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivering intensive therapies to older adults with hematologic malignancies: strategies to personalize care.
    Olin RL
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):63-70. PubMed ID: 31808886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Status as Measured by Geriatric Assessment Predicts Inferior Survival in Older Allogeneic Hematopoietic Cell Transplantation Recipients.
    Huang LW; Sheng Y; Andreadis C; Logan AC; Mannis GN; Smith CC; Gaensler KML; Martin TG; Damon LE; Steinman MA; Huang CY; Olin RL
    Biol Blood Marrow Transplant; 2020 Jan; 26(1):189-196. PubMed ID: 31493541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous hematopoietic cell transplantation for AML in first remission - An abandoned practice or promising approach?
    Yeshurun M; Wolach O
    Semin Hematol; 2019 Apr; 56(2):139-146. PubMed ID: 30926090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular therapies in older adults with hematological malignancies: A case-based, state-of-the-art review.
    Neuendorff NR; Khan A; Ullrich F; Yates S; Devarakonda S; Lin RJ; von Tresckow B; Cordoba R; Artz A; Rosko AE
    J Geriatr Oncol; 2024 Apr; 15(3):101734. PubMed ID: 38430810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of Autologous Hematopoietic Cell Transplantation Compared With Chemotherapy Consolidation Alone for Non-High-Risk Acute Myeloid Leukemia in First Complete Remission in a Minority-Rich Inner-City Cohort With Limited Access to Allografts.
    Adrianzen Herrera D; Kornblum N; Derman O; Bachier-Rodriguez L; Sica RA; Shastri A; Janakiram M; Verma A; Braunschweig I; Mantzaris I
    Clin Lymphoma Myeloma Leuk; 2019 Aug; 19(8):516-521. PubMed ID: 31227357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns and Predictors of Functional Decline after Allogeneic Hematopoietic Cell Transplantation in Older Adults.
    Huang LW; Sheng Y; Andreadis C; Logan AC; Mannis GN; Smith CC; Gaensler KML; Martin TG; Damon LE; Huang CY; Olin RL
    Transplant Cell Ther; 2022 Jun; 28(6):309.e1-309.e9. PubMed ID: 35247612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hematopoietic stem cell transplantation for hematologic malignancies in older adults: geriatric principles in the transplant clinic.
    Wildes TM; Stirewalt DL; Medeiros B; Hurria A
    J Natl Compr Canc Netw; 2014 Jan; 12(1):128-36. PubMed ID: 24453296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haploidentical Hematopoietic Cell Transplant with Post-Transplant Cyclophosphamide and Peripheral Blood Stem Cell Grafts in Older Adults with Acute Myeloid Leukemia or Myelodysplastic Syndrome.
    Slade M; DiPersio JF; Westervelt P; Vij R; Schroeder MA; Romee R
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1736-1743. PubMed ID: 28688919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualizing treatment decisions for older adults with hematologic malignancies.
    Klepin HD; Rizzieri D; Palumbo A; Magarotto V; Eichhorst B
    Am Soc Clin Oncol Educ Book; 2013; ():208-19. PubMed ID: 23714504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serial comprehensive geriatric and quality of life assessments in adults age ≥ 50 years undergoing autologous hematopoietic cell transplantation.
    Nawas MT; Sheng Y; Huang CY; Andreadis C; Martin TG; Wolf JL; Ai WZ; Kaplan LD; Mannis GN; Logan AC; Damon LE; Olin RL
    J Geriatr Oncol; 2021 May; 12(4):531-539. PubMed ID: 33059999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrating geriatric assessment and genetic profiling to personalize therapy selection in older adults with acute myeloid leukemia.
    Bhatt VR; Wichman C; Al-Kadhimi ZS; Koll TT; Fisher AL; Mahato RI; Hyde RK; Berger A; Armitage JO; Holstein SA; Maness LJ; Gundabolu K
    J Geriatr Oncol; 2022 Jul; 13(6):871-874. PubMed ID: 35450817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geriatric assessment in older alloHCT recipients: association of functional and cognitive impairment with outcomes.
    Olin RL; Fretham C; Pasquini MC; Arora M; Bhatt VR; Derman B; Giralt SA; Huang LW; Koll T; Lee SM; Lin RJ; Pang L; Popat UR; Weisdorf DJ; Artz A
    Blood Adv; 2020 Jun; 4(12):2810-2820. PubMed ID: 32574365
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Definition of Unfit for Standard Acute Myeloid Leukemia Therapy.
    Klepin HD
    Curr Hematol Malig Rep; 2016 Dec; 11(6):537-544. PubMed ID: 27681539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological aspects of therapy-related acute myeloid leukemia and myelodysplastic syndrome.
    Chua CC; Fleming S; Wei AH
    Best Pract Res Clin Haematol; 2019 Mar; 32(1):3-12. PubMed ID: 30927972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemia.
    Stone RM; O'Donnell MR; Sekeres MA
    Hematology Am Soc Hematol Educ Program; 2004; ():98-117. PubMed ID: 15561679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence-Based Minireview: Longitudinal geriatric assessment in quality care for older patients with hematologic malignancies.
    Lin RJ; Klepin HD
    Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):59-62. PubMed ID: 31808857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hematopoietic stem cell transplantation in hematologic malignancy.
    Archuleta TD; Devetten MP; Armitage JO
    Panminerva Med; 2004 Mar; 46(1):61-74. PubMed ID: 15238882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcomes of patients with intermediate-risk acute myeloid leukemia treated with autologous hematopoietic cell transplant in first complete remission.
    Mannis GN; Martin TG; Damon LE; Logan AC; Olin RL; Flanders MD; Ai WZ; Gaensler KM; Kaplan LD; Sayre PH; Smith CC; Wolf JL; Andreadis C
    Leuk Lymphoma; 2016 Jul; 57(7):1560-6. PubMed ID: 26490487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.